Maiweibio (688062.SH): has submitted an application for H-share issuance and listing, and has published the application documents.

Maiwei Biotechnology (688062.SH) announced that the company submitted an application to the Hong Kong Stock Exchange on January 6, 2025 for the issuance of H shares and listing on the main board of the Hong Kong Stock Exchange. The application materials for this issuance were also published on the exchange's website on the same day.